Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
35.67
-0.33 (-0.92%)
At close: Oct 23, 2026, 4:00 PM EDT
35.72
+0.05 (0.15%)
After-hours: Oct 23, 2026, 7:57 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $4.79 billion as of October 23, 2026. It is the 3,701st most valuable company in the world and the 1,178th biggest in the United States. Its market cap has increased by 406.77% in one year.
Market Cap
4.79B
Enterprise Value
3.75B
1-Year Change
406.77%
Global Rank
Country Rank
#1,178 United States
Category
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $4.79B, an increase of 705.03%. That is a compound annual growth rate of 36.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 4.79B | 263.36% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.46B |
| Mirum Pharmaceuticals | 5.44B |
| Oruka Therapeutics | 5.29B |
| PTC Therapeutics | 5.23B |
| Scholar Rock Holding | 5.23B |
| Erasca | 5.10B |
| Travere Therapeutics | 5.00B |
| CRISPR Therapeutics AG | 4.90B |